Analgesic and Anti-Inflammatory Effects of Articaine and Perineural Dexamethasone for Mandibular Third Molar Surgery: A Randomized, Double-Blind Study

We aimed to investigate the effectiveness of articaine and perineural dexamethasone (DX) in reducing postoperative sequelae such as swelling and maximum mouth opening that are harming the quality of life of patients after impacted mandibular third molar (IMTM) surgery. We implemented a randomized cl...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of oral and maxillofacial surgery 2020-04, Vol.78 (4), p.507-514
Hauptverfasser: Atalay, Berkem, Şitilci, Abdullah Tolga, Onur, Özen Doğan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 514
container_issue 4
container_start_page 507
container_title Journal of oral and maxillofacial surgery
container_volume 78
creator Atalay, Berkem
Şitilci, Abdullah Tolga
Onur, Özen Doğan
description We aimed to investigate the effectiveness of articaine and perineural dexamethasone (DX) in reducing postoperative sequelae such as swelling and maximum mouth opening that are harming the quality of life of patients after impacted mandibular third molar (IMTM) surgery. We implemented a randomized clinical trial composed of patients undergoing IMTM extraction. The predictor variable was the treatment group. The patients were randomly assigned to 1 of 3 groups: Group A was administered 3.6 mL of articaine mixed with 2 mL of saline solution; group B, 3.6 mL of articaine and 1 mL of DX (4-mg/mL solution) with 1 mL of saline solution; and group C, 3.6 mL of articaine with 2 mL of DX (8-mg/mL solution). The primary outcome variables were swelling (determined by anatomic facial landmarks), pain, and maximum mouth opening. Other variables comprised the duration of surgery, number of analgesics taken in the postoperative period, hygiene, and petechiae. The sample was composed of 60 patients (20 per treatment group), with a mean age of 25.18 ± 5.22 years; 53.3% were women. Postoperative swelling was significantly reduced in groups B and C (P 
doi_str_mv 10.1016/j.joms.2019.10.024
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2320378281</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0278239119312522</els_id><sourcerecordid>2320378281</sourcerecordid><originalsourceid>FETCH-LOGICAL-c400t-92e50df47a7276448f1859b0c03c55d790f736ae537ad03b488c58fbd895bc13</originalsourceid><addsrcrecordid>eNp9kc9u1DAQxi0EotvCC3BAPnIgi__EawdxCW2BSq1AdO-WY49br5K4tRPE9kF4Xhy2cOQ0n2Z-80kzH0KvKFlTQjfvdutdHPKaEdqUxpqw-glaUcFpJYjgT9GKMKkqxht6hI5z3hFCqZCb5-iIU6k4IfUK_WpH099ADhab0eF2nEJ1MfreDIOZYtrjc-_BThlHj9s0BWvCCH_Qb5CKnJPp8Rn8NANMtybHMvQx4atChG7uTcLb25AcvoqLvp7TDaT9e9zi74WIQ3gA9xafxbnrofrYh-J7Pc1u_wI986bP8PKxnqDtp_Pt6Zfq8uvni9P2srI1IVPVMBDE-VoayeSmrpWnSjQdsYRbIZxsiJd8Y0BwaRzhXa2UFcp3TjWis5SfoDcH27sU72fIkx5CttD3ZoQ4Z804I1wqphaUHVCbYs4JvL5LYTBprynRSxx6p5c49BLH0itxlKXXj_5zN4D7t_L3_wX4cACgHPkjQNLZBhgtuJDK27WL4X_-vwH_5pz4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2320378281</pqid></control><display><type>article</type><title>Analgesic and Anti-Inflammatory Effects of Articaine and Perineural Dexamethasone for Mandibular Third Molar Surgery: A Randomized, Double-Blind Study</title><source>Elsevier ScienceDirect Journals</source><creator>Atalay, Berkem ; Şitilci, Abdullah Tolga ; Onur, Özen Doğan</creator><creatorcontrib>Atalay, Berkem ; Şitilci, Abdullah Tolga ; Onur, Özen Doğan</creatorcontrib><description>We aimed to investigate the effectiveness of articaine and perineural dexamethasone (DX) in reducing postoperative sequelae such as swelling and maximum mouth opening that are harming the quality of life of patients after impacted mandibular third molar (IMTM) surgery. We implemented a randomized clinical trial composed of patients undergoing IMTM extraction. The predictor variable was the treatment group. The patients were randomly assigned to 1 of 3 groups: Group A was administered 3.6 mL of articaine mixed with 2 mL of saline solution; group B, 3.6 mL of articaine and 1 mL of DX (4-mg/mL solution) with 1 mL of saline solution; and group C, 3.6 mL of articaine with 2 mL of DX (8-mg/mL solution). The primary outcome variables were swelling (determined by anatomic facial landmarks), pain, and maximum mouth opening. Other variables comprised the duration of surgery, number of analgesics taken in the postoperative period, hygiene, and petechiae. The sample was composed of 60 patients (20 per treatment group), with a mean age of 25.18 ± 5.22 years; 53.3% were women. Postoperative swelling was significantly reduced in groups B and C (P &lt; .05). Maximum mouth opening was significantly increased in groups B and C (P &lt; .05). The results of this study suggest that combining DX with articaine improves the management of discomfort after IMTM surgery. The use of articaine via a mandibular block was not associated with neural damage in our study.</description><identifier>ISSN: 0278-2391</identifier><identifier>EISSN: 1531-5053</identifier><identifier>DOI: 10.1016/j.joms.2019.10.024</identifier><identifier>PMID: 31783004</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Dentistry</subject><ispartof>Journal of oral and maxillofacial surgery, 2020-04, Vol.78 (4), p.507-514</ispartof><rights>2019 American Association of Oral and Maxillofacial Surgeons</rights><rights>Copyright © 2019 American Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c400t-92e50df47a7276448f1859b0c03c55d790f736ae537ad03b488c58fbd895bc13</citedby><cites>FETCH-LOGICAL-c400t-92e50df47a7276448f1859b0c03c55d790f736ae537ad03b488c58fbd895bc13</cites><orcidid>0000-0003-3813-7398</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0278239119312522$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31783004$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Atalay, Berkem</creatorcontrib><creatorcontrib>Şitilci, Abdullah Tolga</creatorcontrib><creatorcontrib>Onur, Özen Doğan</creatorcontrib><title>Analgesic and Anti-Inflammatory Effects of Articaine and Perineural Dexamethasone for Mandibular Third Molar Surgery: A Randomized, Double-Blind Study</title><title>Journal of oral and maxillofacial surgery</title><addtitle>J Oral Maxillofac Surg</addtitle><description>We aimed to investigate the effectiveness of articaine and perineural dexamethasone (DX) in reducing postoperative sequelae such as swelling and maximum mouth opening that are harming the quality of life of patients after impacted mandibular third molar (IMTM) surgery. We implemented a randomized clinical trial composed of patients undergoing IMTM extraction. The predictor variable was the treatment group. The patients were randomly assigned to 1 of 3 groups: Group A was administered 3.6 mL of articaine mixed with 2 mL of saline solution; group B, 3.6 mL of articaine and 1 mL of DX (4-mg/mL solution) with 1 mL of saline solution; and group C, 3.6 mL of articaine with 2 mL of DX (8-mg/mL solution). The primary outcome variables were swelling (determined by anatomic facial landmarks), pain, and maximum mouth opening. Other variables comprised the duration of surgery, number of analgesics taken in the postoperative period, hygiene, and petechiae. The sample was composed of 60 patients (20 per treatment group), with a mean age of 25.18 ± 5.22 years; 53.3% were women. Postoperative swelling was significantly reduced in groups B and C (P &lt; .05). Maximum mouth opening was significantly increased in groups B and C (P &lt; .05). The results of this study suggest that combining DX with articaine improves the management of discomfort after IMTM surgery. The use of articaine via a mandibular block was not associated with neural damage in our study.</description><subject>Dentistry</subject><issn>0278-2391</issn><issn>1531-5053</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9kc9u1DAQxi0EotvCC3BAPnIgi__EawdxCW2BSq1AdO-WY49br5K4tRPE9kF4Xhy2cOQ0n2Z-80kzH0KvKFlTQjfvdutdHPKaEdqUxpqw-glaUcFpJYjgT9GKMKkqxht6hI5z3hFCqZCb5-iIU6k4IfUK_WpH099ADhab0eF2nEJ1MfreDIOZYtrjc-_BThlHj9s0BWvCCH_Qb5CKnJPp8Rn8NANMtybHMvQx4atChG7uTcLb25AcvoqLvp7TDaT9e9zi74WIQ3gA9xafxbnrofrYh-J7Pc1u_wI986bP8PKxnqDtp_Pt6Zfq8uvni9P2srI1IVPVMBDE-VoayeSmrpWnSjQdsYRbIZxsiJd8Y0BwaRzhXa2UFcp3TjWis5SfoDcH27sU72fIkx5CttD3ZoQ4Z804I1wqphaUHVCbYs4JvL5LYTBprynRSxx6p5c49BLH0itxlKXXj_5zN4D7t_L3_wX4cACgHPkjQNLZBhgtuJDK27WL4X_-vwH_5pz4</recordid><startdate>202004</startdate><enddate>202004</enddate><creator>Atalay, Berkem</creator><creator>Şitilci, Abdullah Tolga</creator><creator>Onur, Özen Doğan</creator><general>Elsevier Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-3813-7398</orcidid></search><sort><creationdate>202004</creationdate><title>Analgesic and Anti-Inflammatory Effects of Articaine and Perineural Dexamethasone for Mandibular Third Molar Surgery: A Randomized, Double-Blind Study</title><author>Atalay, Berkem ; Şitilci, Abdullah Tolga ; Onur, Özen Doğan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c400t-92e50df47a7276448f1859b0c03c55d790f736ae537ad03b488c58fbd895bc13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Dentistry</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Atalay, Berkem</creatorcontrib><creatorcontrib>Şitilci, Abdullah Tolga</creatorcontrib><creatorcontrib>Onur, Özen Doğan</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of oral and maxillofacial surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Atalay, Berkem</au><au>Şitilci, Abdullah Tolga</au><au>Onur, Özen Doğan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Analgesic and Anti-Inflammatory Effects of Articaine and Perineural Dexamethasone for Mandibular Third Molar Surgery: A Randomized, Double-Blind Study</atitle><jtitle>Journal of oral and maxillofacial surgery</jtitle><addtitle>J Oral Maxillofac Surg</addtitle><date>2020-04</date><risdate>2020</risdate><volume>78</volume><issue>4</issue><spage>507</spage><epage>514</epage><pages>507-514</pages><issn>0278-2391</issn><eissn>1531-5053</eissn><abstract>We aimed to investigate the effectiveness of articaine and perineural dexamethasone (DX) in reducing postoperative sequelae such as swelling and maximum mouth opening that are harming the quality of life of patients after impacted mandibular third molar (IMTM) surgery. We implemented a randomized clinical trial composed of patients undergoing IMTM extraction. The predictor variable was the treatment group. The patients were randomly assigned to 1 of 3 groups: Group A was administered 3.6 mL of articaine mixed with 2 mL of saline solution; group B, 3.6 mL of articaine and 1 mL of DX (4-mg/mL solution) with 1 mL of saline solution; and group C, 3.6 mL of articaine with 2 mL of DX (8-mg/mL solution). The primary outcome variables were swelling (determined by anatomic facial landmarks), pain, and maximum mouth opening. Other variables comprised the duration of surgery, number of analgesics taken in the postoperative period, hygiene, and petechiae. The sample was composed of 60 patients (20 per treatment group), with a mean age of 25.18 ± 5.22 years; 53.3% were women. Postoperative swelling was significantly reduced in groups B and C (P &lt; .05). Maximum mouth opening was significantly increased in groups B and C (P &lt; .05). The results of this study suggest that combining DX with articaine improves the management of discomfort after IMTM surgery. The use of articaine via a mandibular block was not associated with neural damage in our study.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>31783004</pmid><doi>10.1016/j.joms.2019.10.024</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0003-3813-7398</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0278-2391
ispartof Journal of oral and maxillofacial surgery, 2020-04, Vol.78 (4), p.507-514
issn 0278-2391
1531-5053
language eng
recordid cdi_proquest_miscellaneous_2320378281
source Elsevier ScienceDirect Journals
subjects Dentistry
title Analgesic and Anti-Inflammatory Effects of Articaine and Perineural Dexamethasone for Mandibular Third Molar Surgery: A Randomized, Double-Blind Study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T21%3A00%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Analgesic%20and%20Anti-Inflammatory%20Effects%20of%20Articaine%20and%20Perineural%20Dexamethasone%20for%20Mandibular%20Third%20Molar%20Surgery:%20A%20Randomized,%20Double-Blind%20Study&rft.jtitle=Journal%20of%20oral%20and%20maxillofacial%20surgery&rft.au=Atalay,%20Berkem&rft.date=2020-04&rft.volume=78&rft.issue=4&rft.spage=507&rft.epage=514&rft.pages=507-514&rft.issn=0278-2391&rft.eissn=1531-5053&rft_id=info:doi/10.1016/j.joms.2019.10.024&rft_dat=%3Cproquest_cross%3E2320378281%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2320378281&rft_id=info:pmid/31783004&rft_els_id=S0278239119312522&rfr_iscdi=true